八方电气（苏州）股份有限公司2024 年年度报告 公司代码：603489 公司简称：八方股份 八方电气（苏州）股份有限公司 2024 年年度报告 1 / 197 八方电气（苏州）股份有限公司2024 年年度报告 重要提示 一、本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实性、准确性、 完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、 容诚会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 四、公司负责人王清华、主管会计工作负责人周琴及会计机构负责人（会计主管人员）吴蔚蔚 声明：保证年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 公司拟以实施权益分派股权登记日登记的总股本（扣除公司股份回购专用证券账户持有股数 ）为基数，对全体股东每10股派发现金红利1元（含税），不进行转增股本和送红股。 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告涉及的未来计划、发展战略等前瞻性描述不构成对投资者的实质承诺，敬请投资者注 意投资风险。 七、是否存在被控股股东及 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥54,241,274.96, a decrease of 25.86% compared to ¥73,156,159.83 in the same period last year[5]. - The net profit attributable to shareholders was -¥15,125,989.59, representing a decline of 287.73% from a profit of ¥8,057,481.58 in the previous year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥16,800,503.91, a decrease of 555.82% compared to ¥3,685,783.64 in the same period last year[5]. - The basic earnings per share were -¥0.05, down 266.67% from ¥0.03 in the previous year[5]. - The diluted earnings per share were also -¥0.05, reflecting a 266.67% decrease from ¥0.03 in the same period last year[5]. - The total comprehensive income attributable to the parent company was -15,125,989.59 RMB, compared to 8,057,481.58 RMB in the previous year[20]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,509,986,780.03, down 5.86% from ¥1,604,030,568.64 at the end of the previous year[6]. - The equity attributable to shareholders was ¥966,161,035.57, a decrease of 1.51% from ¥980,970,540.40 at the end of the previous year[6]. - Total liabilities decreased to CNY 424,589,981.04 as of March 31, 2025, from CNY 495,080,870.37 as of December 31, 2024, a reduction of 14.3%[15]. - The company reported a decrease in accounts receivable to CNY 211,694,262.69 as of March 31, 2025, from CNY 243,932,956.28 as of December 31, 2024, a decline of 13.2%[13]. Cash Flow - The net cash flow from operating activities was -¥49,746,084.10, compared to -¥44,949,892.57 in the same period last year[5]. - Cash inflows from operating activities amounted to 77,815,976.32 RMB, an increase from 52,317,227.87 RMB year-over-year[22]. - Cash outflows from operating activities totaled 127,562,060.42 RMB, compared to 97,267,120.44 RMB in the previous year[23]. - The net cash flow from investing activities was -8,550,438.24 RMB, a decline from a positive 29,100,681.84 RMB in the same period last year[23]. - Cash inflows from financing activities were 34,900,000.00 RMB, compared to 16,046,575.29 RMB in the previous year[24]. - The net cash flow from financing activities was -30,743,323.55 RMB, compared to a positive 16,035,023.53 RMB in the previous year[24]. - The ending cash and cash equivalents balance was 69,001,428.88 RMB, down from 74,861,111.35 RMB at the end of the previous year[24]. Operating Costs and Expenses - Total operating costs increased to CNY 83,899,864.35 in Q1 2025, up from CNY 70,123,357.99 in Q1 2024, representing a 19.6% increase[18]. - Research and development expenses for Q1 2025 were CNY 7,235,352.40, compared to CNY 3,531,589.25 in Q1 2024, an increase of 104.8%[19]. - Cash and cash equivalents decreased to CNY 69,962,467.62 as of March 31, 2025, from CNY 160,390,031.32 as of December 31, 2024, a decline of 56.4%[13]. Profitability - Net profit for Q1 2025 was a loss of CNY 23,869,384.04, compared to a profit of CNY 8,057,481.58 in Q1 2024[19]. - Operating profit for Q1 2025 was a loss of CNY 26,468,461.02, down from a profit of CNY 9,361,039.41 in Q1 2024[19].

Financial Performance - The company's operating revenue for 2024 was CNY 1,164,798,937.40, a decrease of 14.93% compared to CNY 1,369,162,256.52 in 2023[22]. - Net profit attributable to shareholders for 2024 was CNY 223,636,488.43, down 20.06% from CNY 279,771,914.08 in 2023[22]. - The basic earnings per share for 2024 was CNY 0.44, reflecting a decline of 20.00% from CNY 0.55 in 2023[23]. - The cash flow from operating activities increased by 26.94% to CNY 422,998,055.82 in 2024, compared to CNY 333,220,661.81 in 2023[24]. - The company's total assets at the end of 2024 were CNY 3,707,374,587.49, a decrease of 1.70% from CNY 3,771,626,052.94 at the end of 2023[22]. - The weighted average return on equity for 2024 was 8.64%, down from 11.17% in 2023, a decrease of 2.53 percentage points[23]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 202,042,109.65, a decrease of 16.33% from CNY 241,487,200.13 in 2023[22]. - The company reported a loss of CNY 8,087,939.59 from the disposal of non-current assets in 2024[29]. - The total cash dividends distributed during the reporting period amounted to RMB 91,287,633.06, representing 40.82% of the net profit attributable to shareholders of the listed company[6]. - The company achieved total revenue of CNY 1,164,798,937.40, a year-on-year decrease of 14.93%[79]. - The company's net profit attributable to shareholders was CNY 22,363.65 million, down 20.06% year-on-year[79]. Research and Development - The company invested 207 million RMB in R&D in 2024, focusing on chemiluminescence instruments, line systems, and core raw materials, resulting in 373 new patent authorizations[41]. - The company is focusing on R&D investments in molecular diagnostic systems and smart laboratories, integrating AI-assisted diagnostic technology with hardware[72]. - The company plans to continue increasing investment in R&D projects to enhance product performance and reduce production costs[43]. - The company has 497 R&D personnel, accounting for 25.53% of the total workforce[96]. - The company emphasizes continuous R&D innovation as a core driver, enhancing comprehensive innovation capabilities to expand terminal coverage in the clinical diagnostic market[70]. Product Development and Innovation - The company launched the fully automated biochemical analyzer CM800 with a throughput of 800 tests per hour, featuring 137 sample positions and 114 reagent positions[60]. - The Metis6000 fully automated biochemical immunoassay line was installed nearly 90 times in 2024, with a total of about 140 installations since its launch, 70% of which were in secondary and lower-level hospitals[36]. - The company has established eight major technology platforms, including POCT, chemiluminescence, biochemical testing, and molecular testing, expanding from low-throughput to high-throughput automated systems[57]. - The company has transitioned from a single POCT product line to a diverse product range, including chemiluminescence and biochemical products, and is expanding into both tiered hospitals and overseas markets[57]. - The company launched the GN7120 fully automatic nucleic acid amplification analyzer, enhancing its product matrix for small and medium hospitals[74]. Market Presence and Expansion - The company has expanded its overseas market presence to cover 130 countries and regions, establishing good cooperation with local distributors and healthcare institutions[64]. - The company plans to expand its overseas market presence, particularly promoting its small luminescence products MAGICL6000 and MAGICL6000i across Europe, Africa, Asia, and Latin America[116]. - The company has established over 2,000 product import licenses in 66 countries as of December 31, 2024, enhancing its international market presence[45]. - The overseas revenue from conventional products reached 137 million RMB, representing a year-on-year growth of 4.53%[44]. - The company has installed nearly 40 units of the CM-400 and approximately 70 units of the MAGICL6000 and MAGICL6000i in overseas markets, indicating strong growth potential[45]. Governance and Compliance - The company has established an independent financial department with a complete accounting system, ensuring financial independence[129]. - The company maintains independent operations with no shared bank accounts with controlling shareholders[130]. - The company has a complete and independent asset structure, with no instances of fund or asset occupation by controlling shareholders[128]. - The board of directors consists of 9 members, including 3 independent directors, ensuring compliance with legal and regulatory requirements[127]. - The company has implemented internal control systems to ensure effective management of subsidiaries and mitigate operational risks[167]. Environmental and Social Responsibility - The company invested 512,300 RMB in environmental protection during the reporting period[172]. - The company ensures that wastewater meets the required standards before being discharged, with regular monitoring of water quality parameters[174]. - The company has implemented measures to control noise pollution, ensuring compliance with relevant noise emission standards[176]. - The company has established a hazardous waste storage facility that meets regulatory requirements and has signed agreements with qualified disposal companies for waste management[176]. - Total donations amounted to 724,000 CNY, with 668,200 CNY in cash contributions[179]. Shareholder Relations and Dividends - The company has committed to a three-year shareholder return plan for 2023-2025, which was approved in the extraordinary shareholder meeting[131]. - The total cash dividend amount for the current period is CNY 91,287,633.06, which represents 40.82% of the net profit attributable to ordinary shareholders[163]. - The company plans to distribute dividends in cash, stock, or a combination of both, with a minimum cash distribution of 10% of the distributable profit for the year if there are no major investment plans or cash expenditures[157]. - The cash dividend distribution ratio is set at a minimum of 80% for mature companies without major expenditures, 40% for mature companies with major expenditures, and 20% for growth-stage companies with major expenditures[158]. - Over the last three accounting years, the cumulative cash dividend amount is CNY 344,864,391.56, with an average annual net profit of CNY 334,106,127.64, resulting in a cash dividend ratio of 103.22%[165].

证券代码：603488 证券简称：展鹏科技 公告编号：2025-017 展鹏科技股份有限公司 2024 年年度业绩预告更正公告 公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对 其内容的真实性、准确性和完整性承担个别及连带责任。 一、本期业绩预告情况 （一）业绩预告期间 2024 年 1 月 1 日至 2024 年 12 月 31 日。 （二）前次业绩预告情况 1、经财务部门初步测算，预计 2024 年年度实现归属于上市公司股东的净利润为 800.00 万元到 1,200.00 万元，与上年同期相比，将减少 6,965.78 万元到 7,365.78 万元，同比减 少 85.30%到 90.20%。 重要内容提示： 2、预计 2024 年年度实现归属于上市公司股东的扣除非经常性损益的净利润为-720.00 万元到-480.00 万元，与上年同期相比，将减少 6,081.75 万元到 6,321.75 万元，同比减少 108.57%到 112.85%。 3、预计 2024 年度实现营业收入 40,000.00 万元到 50,000.00 万元，预计扣除与主营业 务无关的业务收入 ...

基蛋生物科技股份有限公司2025 年第一季度报告 证券代码：603387 证券简称：基蛋生物 基蛋生物科技股份有限公司 2025 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、主要财务数据 (一)主要会计数据和财务指标 单位：元币种：人民币 | | | 本报告期比上年同 | | | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期 期增减变动幅度 | | | | | (%) | | | 营业收入 | 244,148,446.89 | 321,582,715.19 | -24.08 | | 归属于上市公司股东的净利 | 64,307,429.35 | 86,013, ...

八方电气（苏州）股份有限公司2025 年第一季度报告 证券代码：603489 证券简称：八方股份 八方电气（苏州）股份有限公司 2025 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 上年同期 | 本报告期比上年 同期增减变动幅 | | --- | --- | --- | --- | | | | | 度(%) | | 营业收入 | 300,764,124.17 | 295,775,274.91 | 1.69 | | 归属于上市公司股东的净利润 | 21,844,670.32 | 16,535,627.48 ...

Financial Performance - The company's operating revenue for 2024 was RMB 469,138,106.22, a decrease of 6.80% compared to RMB 503,365,193.98 in 2023[21] - The net profit attributable to shareholders of the listed company was RMB 9,963,885.90, down 87.80% from RMB 81,657,794.39 in the previous year[22] - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB -16,428,297.80, a decline of 129.33% compared to RMB 56,017,525.59 in 2023[22] - The net cash flow from operating activities was RMB 24,815,534.82, a decrease of 70.25% from RMB 83,408,976.98 in the previous year[22] - Basic earnings per share decreased by 89.29% to CNY 0.03 in 2024 from CNY 0.28 in 2023[23] - Diluted earnings per share also fell by 89.29% to CNY 0.03 in 2024 compared to CNY 0.28 in 2023[23] - The weighted average return on equity dropped by 7.21 percentage points to 0.99% in 2024 from 8.20% in 2023[23] - The net profit attributable to shareholders for Q1 2024 was CNY 8,057,481.58, while Q2 and Q3 reported losses of CNY 3,471,685.61 and CNY 18,241,531.71 respectively[26] Revenue Breakdown - Total operating revenue for 2024 was CNY 232,402,909.48, with Q3 contributing CNY 90,111,793.23[26] - The elevator industry accounts for over 69.42% of the company's revenue, indicating a strong focus on this sector amidst increasing competition and market consolidation[46] - The military simulation industry contributed ¥138,939,646.76 in revenue, with a gross margin of 54.12%[66] - The company's revenue from the elevator control system products was CNY 330.46 million, while the military simulation system products contributed CNY 138.94 million to the total revenue[71] Asset Management - Total assets increased by 31.44% to RMB 1,604,030,568.64 from RMB 1,220,369,867.13 in 2023[22] - The net assets attributable to shareholders of the listed company decreased by 4.71% to RMB 980,970,540.40 from RMB 1,029,509,947.80 in 2023[22] - The company's trading financial assets increased to 257.78 million RMB, with a fair value change of 11.61 million RMB during the reporting period[81] - The total current assets increased to RMB 947.89 million as of December 31, 2024, compared to RMB 814.04 million as of December 31, 2023, reflecting a growth of approximately 16.4%[200] Investment and Acquisitions - The company completed the acquisition of Beijing Lingwei Military Simulation Technology Co., Ltd. in August 2024, which is now a subsidiary included in the consolidated financial statements[52] - The company acquired a 30.79% stake in Lingwei Junrong, increasing its voting rights to 69.83% after the completion of the acquisition[70] - The company acquired a 41.96% stake in Beijing Lingwei Military Technology Co., Ltd. for approximately 350.83 million RMB, completing the acquisition on August 10, 2024[80] - The company has signed a performance commitment and compensation agreement with the existing shareholders of Lingwei Junrong, which includes specific profit targets for the upcoming years[145] Research and Development - The company’s R&D expenses increased by 5.24% to ¥19,774,527.60[65] - The total R&D expenditure was CNY 19.77 million, accounting for 4.22% of the operating revenue[73] - The company filed 16 utility model patents and 1 invention patent in 2024, with 4 invention patents and 8 utility model patents granted[50] - The company has a strong talent pool in various fields, including frequency control and artificial intelligence, supporting its innovation capabilities[62] Risk Management - The company faces risks from macroeconomic fluctuations affecting market demand, particularly linked to the real estate and urban infrastructure sectors[92] - The company is addressing the risk of intensified market competition by increasing R&D investment and maintaining product and service quality[93] - The company is managing the risk of raw material price fluctuations by improving production processes and cost management[94] - The company is cautious about accounts receivable risks, actively controlling credit limits and selecting partners to mitigate potential bad debt[94] Governance and Compliance - The company has established a governance structure that ensures clear responsibilities and effective checks and balances among the board, supervisory committee, and management[100] - There are no significant differences between the company's governance practices and the regulations set by the China Securities Regulatory Commission[100] - The company has not reported any related party transactions that would impact its governance structure[101] - The company has established a comprehensive internal control system to ensure compliance and accurate financial reporting[131] Future Outlook - The company has committed to achieving a net profit of RMB 4,100 million, RMB 7,000 million, RMB 8,300 million, and RMB 9,300 million for the years 2024 to 2027, totaling no less than RMB 28,700 million[145] - The company plans to invest in R&D for medical rehabilitation devices, leveraging military technology for civilian applications[88] - The company aims to enhance market share by deepening cooperation with existing clients and accelerating the development of new clients, targeting a significant increase in sales by 2025[89] - The company anticipates a shift in the elevator industry towards service-oriented models, driven by increasing maintenance service demand as elevator usage rises[85]

广东迪生力汽配股份有限公司2025 年第一季度报告 证券代码：603335 证券简称：迪生力 广东迪生力汽配股份有限公司 2025 年第一季度报告 广东迪生力汽配股份有限公司2025 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比上年同 | | | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期 期增减变动幅度 | | | | | (%) | | | 营业收入 | 256,686,668.75 | 341,693,889.88 | -24.88 | | 归属于上市公司股东的 ...

Financial Performance - The company's operating revenue for 2024 was RMB 5,106,112,037.02, a decrease of 4.89% compared to RMB 5,368,887,974.75 in 2023[24]. - The net profit attributable to shareholders of the listed company for 2024 was RMB 224,961,752.08, down 30.69% from RMB 324,575,473.13 in 2023[24]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 200,563,209.96, a decrease of 4.61% compared to RMB 210,251,419.28 in 2023[24]. - The net cash flow from operating activities for 2024 was RMB 312,971,987.64, down 7.42% from RMB 338,043,501.97 in 2023[24]. - Basic earnings per share decreased by 31.08% to CNY 0.51 in 2024 from CNY 0.74 in 2023[25]. - Operating cash flow decreased significantly, impacted by a decline in sales revenue, leading to lower cash received from sales[25]. - The weighted average return on equity dropped by 3.28 percentage points to 6.68% in 2024 from 9.96% in 2023[25]. - The company reported a net profit of CNY 160,127,886.45 in Q1 2024, with a significant decrease in subsequent quarters[27]. - Total operating revenue for Q1 2024 was CNY 1,382,344,288.26, reflecting a decrease in sales performance[27]. - The company reported a total revenue of 234.73 million, with a net profit margin of 875.04 million[86]. Investment and Development - The company invested 1.05 billion yuan to establish a subsidiary focused on high and low pressure die-casting products for new energy vehicles, with a production capacity target of 150,000 battery housings and 700,000 shock towers annually[34]. - The company has developed new materials such as high-strength aluminum and magnesium alloys, focusing on lightweight automotive components and integrated casting technology[36]. - The company is committed to developing integrated casting capabilities to meet the growing demand for lightweight vehicle components[36]. - The company completed the development of over a thousand new products and components, enhancing its market competitiveness[57]. - Research and development expenses increased by 11.68% to 206 million RMB, indicating a focus on new product development[44]. Market Trends and Strategy - The penetration rate of new energy vehicles in the automotive market reached 40.9%, with traditional fuel vehicle sales declining significantly[34]. - In 2024, China's automotive production and sales reached 31.23 million and 31.44 million units, respectively, with new energy vehicle production and sales growing by 34.4% and 35.5% year-on-year[37]. - The company aims to enhance its market share with key clients such as Chery, BYD, Geely, and Changan, while also expanding its collaboration with emerging players like Huawei and Xiaomi[74]. - The company plans to accelerate new product development and technological innovation, focusing on high-value new products in the new energy sector to capture more market share[75]. - The company is actively pursuing market expansion through strategic investments and partnerships[66]. Operational Efficiency and Management - The company aims to enhance operational management through cost control measures and improved internal auditing processes[36]. - The company has established a modern enterprise management system to enhance cost control and resource efficiency[44]. - The company is focusing on the development of integrated die-casting technology to reduce component count and improve cost efficiency in new energy vehicle production[73]. - The company has a comprehensive training management system aimed at enhancing employee skills and overall management levels[106]. - The company has implemented comprehensive safety production supervision to prevent accidents and enhance employee training[127]. Governance and Compliance - The company has not violated any decision-making procedures for providing guarantees to external parties[8]. - The company has not faced any requests for extraordinary shareholder meetings from preferred shareholders[83]. - The company has not reported any significant changes in the business operations or competitive landscape that would affect its independence[82]. - The company’s governance structure has been updated with new appointments to enhance management effectiveness[93]. - The company faced regulatory warnings due to the absence of director Chen Xianhong from three board meetings, leading to a warning from the Shanghai Stock Exchange[95]. Shareholder Relations and Dividends - The company plans to distribute a cash dividend of RMB 3.5 per 10 shares, totaling RMB 160,837,911.85, which represents 100.77% of the net profit attributable to shareholders for 2024[6]. - The company has established a cash dividend policy, distributing a total of RMB 153,664,000, which accounts for 47.34% of the net profit attributable to shareholders for 2023[108]. - The company is committed to improving shareholder value through consistent dividend payments and share buyback programs[87]. - The company has maintained a stable profit distribution policy without adjustments during the reporting period[108]. Financial Position and Assets - The total assets at the end of 2024 were RMB 6,805,289,773.43, an increase of 0.73% from RMB 6,756,096,599.76 at the end of 2023[24]. - The net assets attributable to shareholders at the end of 2024 were RMB 3,354,979,204.21, a slight increase of 0.02% from RMB 3,354,385,207.76 at the end of 2023[24]. - The company’s total assets were reported at CNY 3,354,979,204.21, reflecting a solid asset base[200]. - The company’s total liabilities increased to CNY 3,076,000,463.07 from CNY 3,007,827,174.06, reflecting a growth of approximately 2.3% year-over-year[178]. - The company’s cash and cash equivalents decreased to CNY 696,246,896.51 from CNY 1,004,541,647.29, a reduction of approximately 30.6%[179]. Risks and Challenges - The company faces risks including intensified market competition, rising raw material prices, and potential talent shortages as it scales operations[77]. - The company has received regulatory warnings due to the failure of its controlling shareholder to timely disclose share reductions, leading to increased training on compliance for key personnel[138]. - The company has not encountered any delisting risks or significant financial irregularities[137]. Corporate Social Responsibility - The company has invested a total of 90,000 yuan in poverty alleviation and rural revitalization projects, benefiting local communities[128]. - The company has engaged in charitable donations totaling RMB 208,000, benefiting various community projects[126]. - The company donated 100,000 yuan annually to the Jiangsu Charity Association, demonstrating its commitment to social responsibility[127].

Financial Performance - Operating revenue for Q1 2025 reached RMB 1,131,735, an increase of 3.29% compared to RMB 1,095,689 in the same period last year[5] - Net profit attributable to shareholders was RMB 439,861, reflecting a growth of 6.19% from RMB 414,204 year-on-year[5] - Basic earnings per share rose to RMB 0.24, up 4.35% from RMB 0.23 in the same period last year[5] - The bank's operating profit for Q1 2025 was CNY 492,131 thousand, an increase of 9.2% from CNY 450,704 thousand in Q1 2024[29] - Investment income rose to CNY 454,941 thousand in Q1 2025, compared to CNY 300,288 thousand in Q1 2024, reflecting a growth of 51.4%[29] Cash Flow and Liquidity - Net cash flow from operating activities improved significantly to RMB 1,581,934, a 166.03% increase from a negative cash flow of RMB -2,395,793 in the previous year[5] - Cash flow from operating activities generated a net cash inflow of CNY 1,581,934 thousand in Q1 2025, a significant improvement compared to a net outflow of CNY 2,395,793 thousand in Q1 2024[31] - The net increase in cash and cash equivalents was -390,959 thousand, compared to -615,153 thousand in the previous period[32] - The beginning balance of cash and cash equivalents was 4,135,655 thousand, down from 5,051,417 thousand[32] - The ending balance of cash and cash equivalents was 3,744,696 thousand, a decrease from 4,436,264 thousand[32] Asset and Liability Management - Total assets at the end of Q1 2025 were RMB 221,889,802, representing a 3.69% increase from RMB 213,987,100 at the end of the previous year[5] - The bank's total liabilities increased to CNY 203,514,528 thousand as of March 31, 2025, compared to CNY 195,931,400 thousand at the end of 2024, marking an increase of approximately 3.0%[28] - The total loans amounted to CNY 133.22 billion, reflecting a growth of 3.00% year-to-date[13] - Total deposits increased to CNY 179.08 billion, marking a 5.19% rise since the start of the year[13] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 30,477, with the top 10 shareholders holding a combined 36.81% of shares[9] - The company’s capital adequacy ratio was reported at 12.91%[24] Operational Efficiency - The cost-to-income ratio improved to 30.62%, down from 35.22% in the previous year[22] - The non-performing loan ratio stood at 0.90%, with a provision coverage ratio of 420.03% as of March 31, 2025[13] Strategic Focus - The company continues to focus on supporting private economic development and promoting inclusive finance[13] - The company conducted 11 investor communication activities during the reporting period[11] Other Financial Metrics - Non-recurring gains and losses totaled RMB 3,129, with government subsidies contributing RMB 4,498[7] - Significant changes in financial data included a 2,311.91% increase in interbank and other financial institutions' deposits due to financing strategy adjustments[8] - The weighted average return on equity decreased by 0.20 percentage points to 2.39% compared to 2.59% in the previous year[5] - Net interest income decreased to CNY 703,412 thousand in Q1 2025, down 2.9% from CNY 724,479 thousand in the same period last year[29]